You're sitting in a meeting and the word disappears mid-sentence. You read the same paragraph three times and it doesn't land. By 2pm your brain is done, even when your body isn't. You used to be the sharpest person in the room. Now you're compensating, and hoping nobody notices.

This is not aging. This is not stress. This is not you becoming less capable. There is a specific, measurable biological mechanism happening in your cells right now — and the fact that nobody has explained it to you is a failure of medicine, not a reflection of your intellect.

Here is what is actually going on.

The mechanism

Estrogen Does More Than You Were Told

Most women are taught that estrogen governs reproduction. What most women are never told is that estrogen also plays a critical role in brain energy metabolism. Estradiol — the primary form of estrogen — is one of the body's most important regulators of mitochondrial efficiency. When it drops, an entirely separate system begins to fail.

Here is the cascade, in plain language.

When estrogen drops, it triggers the overactivation of an enzyme called CD38. CD38 essentially consumes your NAD⁺ — nicotinamide adenine dinucleotide — the coenzyme your mitochondria need to produce cellular energy. By the time a woman reaches her mid-40s, her NAD⁺ levels have typically dropped 40–50% from their peak.

The prefrontal cortex — the part of your brain responsible for word retrieval, executive function, decision-making, and complex thought — is the most energy-hungry region in the body. When NAD⁺ drops, it is starved of fuel first. This is not a coincidence. It is the biological explanation for exactly what you are experiencing.

What this feels like

The Symptoms Are Specific. So Is the Biology.

Women in perimenopause describe cognitive symptoms in remarkably consistent language. Not because they have read the same articles. Because the underlying biology is the same. The prefrontal cortex has a specific failure signature when it is fuel-deprived — and it produces a specific set of experiences.

These are not descriptions of aging. They are descriptions of a specific energy deficit in a specific brain region. Word retrieval failure, processing speed reduction, executive function degradation — these map directly onto the cognitive demands of the prefrontal cortex, and directly onto the NAD⁺-dependent processes it relies on.

The second failure

The Cholinergic System Loses Its Anchor

The cognitive impact of perimenopause doesn't stop at energy depletion. Estrogen also acts as a primary regulator of the cholinergic system — the network of neurons and receptors that govern learning, memory, and the speed at which your brain processes information.

Acetylcholine is the neurotransmitter at the center of this system. Estrogen supported its synthesis and protected the receptors that receive it. When estrogen drops, acetylcholine synthesis drops with it. Processing speed slows. Word retrieval — which depends on rapid, high-fidelity signaling across neural networks — becomes unreliable.

This is why cognitive symptoms in perimenopause are not random. They follow a pattern: verbal fluency goes first, followed by processing speed, followed by working memory under stress. This is the cholinergic failure signature.

What you were told vs. what is true

You Were Not Imagining It.

Only 7% of medical residents feel adequately prepared to treat menopausal patients. Cognitive symptoms of perimenopause are consistently underdiagnosed, frequently dismissed as anxiety or depression, and almost never explained mechanistically to the women experiencing them.

You were told it was stress. You were told it was getting older. You were told to sleep more, drink less coffee, take a multivitamin. None of these addressed the actual mechanism — because the actual mechanism was never explained to you.

The estrogen → CD38 → NAD⁺ → mitochondrial failure pathway is not a hypothesis. It is a documented, peer-reviewed biological cascade. The cognitive symptoms that result from it are not vague or subjective. They are predictable, specific, and addressable.

The path forward

What Addressing the Mechanism Actually Looks Like

Understanding the mechanism reframes the solution. If the problem is NAD⁺ depletion driven by CD38 overactivation, the intervention needs to bypass that bottleneck and restore cellular fuel directly.

NMN (nicotinamide mononucleotide) is a direct NAD⁺ precursor — meaning it converts to NAD⁺ in the cell without going through the enzymatic steps that CD38 compromises. At a clinically relevant dose of 500mg, it restores mitochondrial ATP production in the prefrontal cortex. Not by stimulating the nervous system. By returning the fuel supply to normal.

This takes time. NAD⁺ levels don't recover overnight. But the mechanism is not mysterious, the timeline is predictable, and the outcome — restored cellular energy, reduced cognitive fog, more reliable word retrieval — is the logical result of addressing the underlying cause rather than managing the downstream symptoms.